Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs144628392 | chr17:15464351 | G/A | 4.1E-7 | 170 | 15.77 | 12.67 | 3.67 | KM Plot |
| PAAD | rs144932074 | chr2:217911285 | C/CT | 5.19E-5 | 178 | 15.97 | 14.33 | 7.2 | KM Plot |
| PAAD | rs145061325 | chr17:26903111 | TCTC/T | 1.67E-5 | 175 | 15.48 | 16.05 | 3.67 | KM Plot |
| PAAD | rs145112635 | chr17:12912043 | AAG/A | 3.49E-6 | 177 | 16.05 | 15.47 | 7.77 | KM Plot |
| PAAD | rs145204153 | chr12:104728978 | CTTT/C | 2.76E-12 | 171 | 1.37 | 15.08 | 15.48 | KM Plot |
| PAAD | rs145576611 | chr1:227516288 | C/CT | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs145589901 | chr1:227536669 | C/T | 1.03E-5 | 175 | 15.55 | 15.65 | 3.9 | KM Plot |
| PAAD | rs145722452 | chr1:227323304 | C/T | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs145851120 | chr1:227591896 | G/A | 5.64E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs145959422 | chr3:175808801 | AC/A | 8.21E-5 | 177 | 15.62 | 15.48 | 4.1 | KM Plot |
| PAAD | rs146124341 | chr1:162830985 | CCCTCCCTA/C | 9.48E-6 | 178 | 15.4 | 16.37 | 6.5 | KM Plot |
| PAAD | rs146169632 | chr2:70503308 | CT/C | 0 | 172 | 15.42 | 17.4 | 1.03 | KM Plot |
| PAAD | rs146176640 | chr1:227478144 | C/CT | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs146231559 | chr19:49355128 | A/G | 1.44E-12 | 173 | 16.2 | 12.6 | 1.37 | KM Plot |
| PAAD | rs146435989 | chr1:227493575 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |